Immunomodulatory influence by interferon alpha and imatinib mesylate in chronic myeloid leukemia

被引：0
|
作者：
Yokoyama, Kazuaki [1 ,2 ]
Nagamura-Inoue, Tokiko [1 ,2 ]
Nakayama, Shin [1 ,2 ]
Ishige, Ikuo [1 ,2 ]
Ohno, Nobuhiro [1 ]
Takahashi, Satoshi [1 ]
Uchimaru, Kaoru [1 ]
Iseki, Toru [1 ,3 ]
Tojo, Arinobu [1 ,2 ]
机构：
[1] Univ Tokyo, Res Hosp Inst Med Sci, Dept Hematol Oncol, Tokyo, Japan
[2] Univ Tokyo, Res Hosp Inst Med Sci, Dept Cell Process & Transfus, Tokyo, Japan
[3] Chiba Univ, Sch Med, Dept Blood Transfus, Chiba 280, Japan
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.4534.4534
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4534
引用
收藏
页码：205B / 205B
页数：1
相关论文
共 50 条
  • [1] Imatinib Mesylate in Chronic Myeloid Leukemia
    Mishra, Pravas
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2007, 28 (01) : 5 - 6
  • [2] Spotlight on Imatinib Mesylate in Chronic Myeloid Leukemia
    Monique P. Curran
    Katherine F. Croom
    Karen L. Goa
    BioDrugs, 2004, 18 : 207 - 210
  • [3] Treatment of chronic myeloid leukemia with imatinib mesylate
    Ohno R.
    International Journal of Clinical Oncology, 2006, 11 (3) : 176 - 183
  • [4] Spotlight on imatinib mesylate in chronic myeloid leukemia
    Curran, MP
    Croom, KF
    Goa, KL
    BIODRUGS, 2004, 18 (03) : 207 - 210
  • [5] Imatinib mesylate and treatment of chronic myeloid leukemia
    Yamada, Hisashi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 106 : 39P - 39P
  • [6] Therapy with Imatinib Mesylate for Chronic Myeloid Leukemia
    Arora, Brijesh
    Kumar, Lalit
    Kumari, Mamta
    Sharma, Atul
    Wadhawa, Jyoti
    Kochupillai, V
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2005, 26 (02) : 5 - +
  • [7] Imatinib mesylate for the treatment of chronic myeloid leukemia
    Soverini, Simona
    Martinelli, Giovanni
    Lacobucci, Ilaria
    Baccarani, Michele
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (06) : 853 - 864
  • [8] Cytogenetic remissions induced by interferon α and imatinib mesylate are immunologically distinct in chronic myeloid leukemia
    Nakayama S.
    Nagamura-Inoue T.
    Yokoyama K.
    Ohno N.
    Ooi J.
    Takahashi S.
    Uchimaru K.
    Iseki T.
    Tojo A.
    International Journal of Hematology, 2007, 86 (3) : 208 - 211
  • [9] Cytogenetic remissions induced by interferon α and imatinib mesylate are immunologically distinct in chronic myeloid leukemia
    Nakayama, Shin
    Nagamura-Inoue, Tokiko
    Yokoyama, Kazuaki
    Ohno, Nobuhiro
    Ooi, Jun
    Takahashi, Satoshi
    Uchimaru, Kaoru
    Iseki, Toru
    Tojo, Arinobu
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2007, 86 (03) : 208 - 211
  • [10] Results of imatinib mesylate therapy in chronic myeloid leukemia
    Altintas, Abdullah
    Cil, Timucin
    Ayyildiz, Orhan
    Kaplan, Mehmet A.
    Isikdogan, Abdurrahman
    Muftuoglu, Ekrem
    Atay, Ahmet E.
    ANNALS OF ONCOLOGY, 2006, 17 : 211 - 211
12345